Zalicus being silent for long time, even did not release Z944 PI result..
Recently Zalicus officers got nice exit package for a reason.
Recently departure of Board director Todd Foley who run MPM Novartis Fund.
Zalicus got Patents for both Z160 and Z944.
Big pharma can own Z160, Z944, Z212 and the whole ICBs pipelines, Prednisporin, CHTS for a fraction of 500 million Merck spent for only Z160 parntering.
Big pharma run out of patents, need new drugs especially non-narcotic pain drugs. FDA is pushing to have non narcotic pain drug. Icagen bought out, Convergence partnering, only Zalicus left.
Corrigan is negotiating with some big pharma for partnership or buyout!